Fifth Third Bancorp
AURA icon

Fifth Third Bancorp’s Aura Biosciences AURA Stock Holding History

Fifth Third Bancorp’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46K Hold
488
– – ﹤0.01% 4004
2026
Q1 		$3.27K Buy
+488
New +$2.8K ﹤0.01% 3950

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fifth Third Bancorp's AURA Position: Q2 2026 in Review

Fifth Third Bancorp held its Aura Biosciences (AURA) position steady in Q2 2026 at 488 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4004.

Fifth Third Bancorp first reported a position in AURA in Q1 2026 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Fifth Third Bancorp held 488 shares of Aura Biosciences worth $3.46K as of Q2 2026.
  • Fifth Third Bancorp left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4004 holding.
  • Fifth Third Bancorp first reported a position in Aura Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.